Skip to main content

Advertisement

Table 1 Subject demographics and neuropsychological assessments

From: Anxiety correlates with cortical surface area in subjective cognitive decline: APOE ε4 carriers versus APOE ε4 non-carriers

  SCD (n = 65) NC (n = 73) P value
Age (years) 65.85 (4.85) 64.55 (5.52) .147
Education 11.86 (2.70) 11.68 (3.31) .734
Gender (male/female) 23/42 38/35 .138
APOE ε4 (+/−)a 16/48 14/56 .443
MMSE 28.65 (1.23) 28.79 (1.38) .866
MoCA-B 25.25 (2.36) 25.79 (2.48) .338
AVLT-IR 6.50 (1.13) 6.66 (1.68) .432
AVLT-DR 6.57 (1.84) 6.95 (2.20) .166
AVLT-R 21.95 (1.74) 22.56 (1.46) .005
STT-A 63.49 (16.42) 64.56 (22.94) .112
STT-B 143.85 (37.44) 139.22 (37.24) .913
AFT 17.88 (4.28) 18.81 (4.60) .232
BNT 24.74 (2.45) 25.26 (3.14) .396
GDS 3.35 (3.16) 1.89 (1.80) .382
HAMD 5.66 (4.26) 2.51 (2.64) < .001
HAMA 6.34 (4.70) 2.65 (2.43) < .001
  1. APOE apolipoprotein E, MMSE Mini-Mental State Examination, MOCA-B Montreal Cognitive Assessment Basic Version, AVLT-IR Auditory Verbal Learning Test-immediate recall, AVLT-DR Auditory Verbal Learning Test-delay recall, AVLT-R Auditory Verbal Learning Test-recognition, STT-A Shape Trails Test Part A, STT-B Shape Trails Test Parts B, AFT semantic fluency (animals), BNT Boston Naming Test, GDS Geriatric Depression Scale, HAMD Hamilton Depression Rating Scale, HAMA Hamilton Anxiety Rating Scale
  2. aAPOE genotype results were included in SCD subjects (N = 64) and controls (N = 70)